Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) are reaching global epidemic proportions. Lack of non-invasive diagnostic tools and effective therapies constitute two of the major hurdles for a bona fide treatment and a reversal of NASH progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Rom, Oren, Xu, Guan, Guo, Yanhong, Zhu, Yunhao, Wang, Huilun, Zhang, Jifeng, Fan, Yanbo, Liang, Wenying, Lu, Haocheng, Liu, Yuhao, Aviram, Michael, Liu, Zhipeng, Kim, Seongho, Liu, Wanqing, Wang, Xueding, Chen, Y. Eugene, Villacorta, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444056/
https://www.ncbi.nlm.nih.gov/pubmed/30772307
http://dx.doi.org/10.1016/j.ebiom.2019.02.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444056/
https://www.ncbi.nlm.nih.gov/pubmed/30772307
http://dx.doi.org/10.1016/j.ebiom.2019.02.019

Ejemplares similares